Key result
Subjects with the C825T variant had higher percentage body fat (p=0.02) and BMI (p=0.03) compared with noncarriers, but showed no difference in insulin sensitivity.
Why the study?
Is the C825T polymorphism of the G protein beta3 subunit associated with obesity and insulin sensitivity in normal and impaired glucose tolerant subjects?
Observational (n=774)
Is the C825T polymorphism of the G protein beta3 subunit associated with obesity and insulin sensitivity in normal and impaired glucose tolerant subjects?
p-value: p=0.02
The C825T polymorphism in the G protein beta3 subunit is associated with increased body fat and BMI but not with insulin sensitivity in a German population.
C825T variant may associate with higher adiposity independent of insulin sensitivity; leaves open causal role and warrants prospective validation.
OBJECTIVE: The common C825T polymorphism of the gene that encodes the G protein beta3 subunit has been shown to influence lipolysis in human adipocytes and to be associated with hypertension, body fat distribution, and obesity. In addition, it has been shown to be associated with insulin resistance in a small group of hypertensive subjects. We investigated whether this polymorphism contributed to the variability in obesity in our population from southern Germany and whether it was associated with insulin sensitivity of lipolysis and/or glucose disposal. RESEARCH METHODS AND PROCEDURES: We determined percentage body fat, body fat distribution, glucose tolerance [oral glucose-tolerance test (OGTT)], insulin sensitivity, and serum free fatty acids using data from OGTTs (N = 774) and clamp (euglycemic hyperinsulinemic clamp, N = 216) in normal and impaired glucose tolerant subjects who were genotyped for this polymorphism. RESULTS: Compared with noncarriers of the C825T mutation, subjects with the C825T variant (prevalence approximately 32%) had higher percentage body fat (p = 0.02) and higher BMI (p = 0.03). No conclusive effect was seen on serum free fatty acids measured either during fasting or at the end of a 2-hour OGTT. Insulin sensitivity determined during the OGTT and during the clamp, both adjusted for age, gender, and percentage body fat, was not different between the genotypes (p = 0.33 and p = 0.48, respectively). DISCUSSION: We have concluded that the C825T polymorphism in the G protein beta3 subunit played an important role in the determination of obesity in this German population. However, it probably had no direct effects on insulin sensitivity of lipolysis and glucose disposal.
No takes yet. Share an insight, caveat, or question.
Stefan et al. (2004) conducted an observational in Normal and impaired glucose tolerance (n=774). C825T variant of the G protein β3 subunit vs. Noncarriers of the C825T mutation was evaluated on Percentage body fat and BMI (p=0.02). Subjects with the C825T variant had higher percentage body fat (p=0.02) and BMI (p=0.03) compared with noncarriers, but showed no difference in insulin sensitivity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: